lorcaserin(856681-05-5)is an orally administered agent and a selective 5-ht2c receptor agonist for the treatment of obesity. it had been approved for marketing in us by fda on 27 june in 2012. in clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
2,6-dioxopiperidine-3-ammonium chloride basic information |
product name: | 2,6-dioxopiperidine-3-ammonium chloride |
synonyms: | 2,6-dioxopiperidine-3-ammonium chloride;3-amino piperdine-2,6-dion hydrochloride;3-amino-2,6-piperidinedione hydrochloride;2,6-piperidinedione, 3-amino-, hydrochloride;glutamic acid imide hydrochloride;3-amino-2,6-dioxo-piperidine hydrochloride ,99%;3-amino-2,6-piperidinedione hcl;3-amino-2,6-dioxo-piperidine hydrochloride |
cas: | 24666-56-6 |
mf: | c5h9cln2o2 |
mw: | 164.59016 |
einecs: | |
product categories: | |
mol file: | 24666-56-6.mol |
2,6-dioxopiperidine-3-ammonium chloride chemical properties |
safety information |
2,6-dioxopiperidine-3-ammonium chloride usage and synthesis |
chemical properties | white crystal |
2,6-dioxopiperidine-3-ammonium chloride preparation products and raw materials |